137 related articles for article (PubMed ID: 38728472)
1. Effects of microbiome-based interventions on neurodegenerative diseases: a systematic review and meta-analysis.
Chui ZSW; Chan LML; Zhang EWH; Liang S; Choi EPH; Lok KYW; Tun HM; Kwok JYY
Sci Rep; 2024 Apr; 14(1):9558. PubMed ID: 38664425
[TBL] [Abstract][Full Text] [Related]
2. Pathology of pain and its implications for therapeutic interventions.
Cao B; Xu Q; Shi Y; Zhao R; Li H; Zheng J; Liu F; Wan Y; Wei B
Signal Transduct Target Ther; 2024 Jun; 9(1):155. PubMed ID: 38851750
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of microbiota modulation: Implications for health, disease, and therapeutic interventions.
Ugwu OP; Alum EU; Okon MB; Obeagu EI
Medicine (Baltimore); 2024 May; 103(19):e38088. PubMed ID: 38728472
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal involvement of autism spectrum disorder: focus on gut microbiota.
Settanni CR; Bibbò S; Ianiro G; Rinninella E; Cintoni M; Mele MC; Cammarota G; Gasbarrini A
Expert Rev Gastroenterol Hepatol; 2021 Jun; 15(6):599-622. PubMed ID: 33356668
[TBL] [Abstract][Full Text] [Related]
5. The impact of modulating the gastrointestinal microbiota in cancer patients.
Morkūnas E; Skiecevičienė J; Kupčinskas J
Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
[TBL] [Abstract][Full Text] [Related]
6. Role of the gastrointestinal microbiota in small animal health and disease.
Redfern A; Suchodolski J; Jergens A
Vet Rec; 2017 Oct; 181(14):370. PubMed ID: 28916525
[TBL] [Abstract][Full Text] [Related]
7. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study.
Kang DW; Adams JB; Gregory AC; Borody T; Chittick L; Fasano A; Khoruts A; Geis E; Maldonado J; McDonough-Means S; Pollard EL; Roux S; Sadowsky MJ; Lipson KS; Sullivan MB; Caporaso JG; Krajmalnik-Brown R
Microbiome; 2017 Jan; 5(1):10. PubMed ID: 28122648
[TBL] [Abstract][Full Text] [Related]
8. Human microbiome restoration and safety.
Daliri EB; Tango CN; Lee BH; Oh DH
Int J Med Microbiol; 2018 Jul; 308(5):487-497. PubMed ID: 29773467
[TBL] [Abstract][Full Text] [Related]
9. Early life exposure of infants to benzylpenicillin and gentamicin is associated with a persistent amplification of the gut resistome.
Patangia DV; Grimaud G; O'Shea CA; Ryan CA; Dempsey E; Stanton C; Ross RP
Microbiome; 2024 Feb; 12(1):19. PubMed ID: 38310316
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota alterations in acute myocardial infarction: (diabetic) context is everything.
Lymperopoulos A
Ann Transl Med; 2023 Dec; 11(12):404. PubMed ID: 38213814
[No Abstract] [Full Text] [Related]
11. Molecular Insights Into the Role of Gut Microbiota in Antibiotic Therapy Selection and Resistance Mitigation.
Andreescu M
Cureus; 2023 Dec; 15(12):e50318. PubMed ID: 38089944
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey.
Parigi TL; Vieujean S; Paridaens K; Dalgaard K; Peyrin-Biroulet L; Danese S
Microorganisms; 2023 Nov; 11(11):. PubMed ID: 38004817
[TBL] [Abstract][Full Text] [Related]
13. A systematic review on diagnosis and treatment of gastrointestinal diseases by magnetically controlled capsule endoscopy and artificial intelligence.
Wang X; Hu X; Xu Y; Yong J; Li X; Zhang K; Gan T; Yang J; Rao N
Therap Adv Gastroenterol; 2023; 16():17562848231206991. PubMed ID: 37900007
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
